The study found that participants using the AI application achieved optimal insulin dosing more quickly, exhibited higher insulin adherence, experienced better glycemic control, and reported reduced diabetes‐related emotional distress compared to those receiving standard care. This evidence concerns the gene INS and diabetes mellitus.